We are PharmaSens

We at PharmaSens are devoted to simplifying diabetes management. We are passionate about technology bringing more people with diabetes towards better treatment and a life with increased freedom.

Our devices are developed with the highest quality standards in engineering. We know that perfect performance is of life-saving importance.

We are PharmaSens

—

We are a privately held Swiss company, located in Biel.

—

We involve users early and constantly in our development.

—

We have an expert team experienced in developing and bringing products to market for people living with diabetes.

—

We have strong collaborations and valuable partnerships with the medical device/pump development and manufacturing community.

—

We hold several granted patents, have pending applications and guaranteed freedom to operate for our technologies.

Meet the team

Marcel Both
Chief Executive Officer
  • CEO experience from five different companies
  • Insulin pump development and launch
  • Combination product development and launch
  • Degree in Electrical Engineering
Nicole Bernini
Product Management & Marketing
  • 20 years in product management and project marketing
  • Insulin pumps, continuous glucose monitoring, combination systems
  • Disetronic Medical Systems, Roche Diabetes Care, yband AG
  • Degree in Business Management / Marketing
Anna Martensson
Business Development & Project Management
  • +20 years in medical devices
  • Business and product development, project management
  • J&J, Vitrolife, Decomplix, Biosafe (now Cytiva)
  • Degree in Mechanical Engineering
Gilbert Schiltges
Product Development
  • 19 years R&D leadership experience
  • 13 years experience in R&D medical devices
  • LEGO, Roche, Meyer Burger, Bystronic
  • PhD in Mechanics
Thomas Moeller
Chief Financial Officer
  • More than 30 years of finance experience
  • 21 years of Venture Capital experience
  • Executed 22 Investments/Exits and raised 4 Venture Funds in Life Science
  • Degree in Economics and certified accountant
Serge Hügli
Industrialisation & Manufacturing
  • 20 years in industrialization of industrial and medical products
  • Insulin pump and accessories launch
  • Disetronic, Roche, Staufen Inova
  • Degree in Mechanical Engineering and Business Administration (EMBA)
Dr. Michael Schoemaker
Expert Sensor Technology
  • 25+ years’ experience in research and development of glucose sensors
  • Disetronic; Roche Diagnostics, Agileus Consulting
  • PhD in Biochemistry
Kurt Friedli
Hardware & Software Development
  • More than 30 years in the development and manufacturing of single fault safe, reliable, and robust infusion and insulin pumps
  • Disetronic Medical System, Roche Diabetes Care
  • Degree in Electrical Engineering and Business Administration
David Teutsch
Product Development
  • 17 years in medical devices
  • Technology and product development
  • Roche, Ypsomed, Phonak, Comet AG
  • Degree in Microtechnology
Andreas Walter
Product Development
  • 7 years in medical devices, 10 years in R&D
  • Product development and global product launch
  • Komax, Gambro (now Baxter), Medela
  • Degree in Life Science Technologies and Polymer Engineering
Radek Skupienski
Sensor Technology
  • More than 10 years in research and industry
  • Federal Institute of Technology, Lausanne University Hospital, BASF
  • Degree in Chemistry, PhD in Neuroscience
Adrian Auderset
Product Development
  • 20 years in medical device
  • Innovation and product development
  • Switzerland Innovation Park, Cendres+Métaux
  • Degree in Engineering and Innovation
Catherine Destribois
Laboratory Technician
  • More than 20 years in a medical laboratory in diabetology and nephrology hospital department
  • 5 years in management, production and quality control in a Swiss Red Cross blood bank
  • Degrees in Biomedical Analysis and Medical Coding
Caroline Bernhard
Executive Assistant
  • 20 years in hotel and tourism business
  • Administration, marketing and human resources
  • Hotel management experience
  • Degree in hotel management, administration and education

Scientific Advisory Board

Prof. em. Dr. med. Peter Diem

Prof. Peter Diem is Chair of the Scientific Advisory Board at PharmaSens. He is a Medical Doctor and Professor Emeritus of Endocrinology, Diabetes, and Nutrition at the University Hospital Bern, Switzerland. Prof. Diem also serves as President of diabetesschweiz (Swiss Diabetes Association, www.diabetesschweiz.ch). His primary expertise is in the individualized optimization of diabetes care, particularly through advancing treatment personalization and patient outcomes in endocrinology and diabetes management.

Assoz. Prof. Dr. med. Julia Mader

Julia Mader is Associate Professor of Medicine at the Division of Endocrinology and Diabetology at Medical University of Graz and Deputy Head of the Diabetes Outpatient Clinic. Her research focuses on diabetes technology with emphasis on insulin pumps, continuous glucose monitoring, automated insulin delivery systems and decision support systems.

Prof. rer. nat. Dr. Lutz Heinemann

Lutz Heinemann is a member of national and international diabetes associations. He also sits on the Scientific Advisory Boards of various pharmaceutical and diagnostics companies. Since 2011, he has been the Managing Editor of the Journal of Diabetes Science and Technology. Professor Heinemann’s research is focused on insulin pharmacology and diabetes technology.

Prof. Dr. med. Pierre-Yves Benhamou

Pierre-Yves Benhamou is Professor of Endocrinology and Metabolism at University Hospital Grenoble Alpes, France, and an endocrinologist with a main clinical focus on type 1 diabetes, namely cell therapy, islet transplantation and innovative technologies. Professor Benhamou is also appointed chief medical officer at Diabeloop SA in the field of automated insulin delivery systems.

Dr. med. Guido Freckmann

Guido Freckmann is Medical Director and CEO of The Institute for Diabetes Technologies (IfDT) at the Ulm University, Germany. IfDT is an independent organization specialized on clinical research in the area of the testing of systems for continuous glucose monitoring (CGM) and insulin pumps. Dr. Freckmann has more than 20 years experience in advanced studies of medical devices for diabetes therapy.

Prof. Dr. med. Kirsten Nørgaard

Kirsten Nørgaard is heading the research group Diabetes Technology Research at Steno Diabetes Center Copenhagen, Denmark and an active clinician focusing on adults with type 1 diabetes at the the clinic serving 11,000 patients. She is a professor at University of Copenhagen, and has for years provided education courses for patients, students, and health care professionals nationally and internationally in the use of diabetes technology. Her research interest is broadly within optimal treatment possibilities for type 1 and type 2 diabetes using different types of technologies.

Board of Directors

Dr. Jean Patricot

Jean Patricot is an experienced international executive with more than 25 years of managerial experience in the diabetes area, as General Manager of LifeScan (blood glucose monitoring systems) and Head of OUS markets for Animas (insulin pumps), member of the global management board and former Director EMEA at Johnson & Johnson.

Prof. Urs A. Meyer

Urs Meyer is Medical Doctor, Professor em. of Pharmacology, Biozentrum, University of Basel, Switzerland. Former Chairman of the Biozentrum. Extensive experience as advisor to organizations (WHO, INH, FDA) and companies in the field of biotechnology, drug development and medical devices in relation to personalized and precision medicine.

Sujay Hamlai

Sujay Hamlai is a prominent business leader with expertise in diverse industries, including healthcare, real estate, and manufacturing. He has fostered collaborations within the medical device sector, driving innovation and growth across the international market. MBA from Western Michigan University, USA.

Gregor Zünd

Gregor Zünd, former CEO of University Hospital Zurich, is a cardiovascular surgeon and medical researcher. Beyond his leadership role, he has been deeply involved in advancing healthcare innovation, collaborating with the medical device industry to drive cutting-edge technological developments and improve patient outcomes.

James Peterson

James Peterson is retired CEO of the public medtech company Haemonetics (NYSE:HAE). At the inspiration of his diabetic daughter, he founded two insulin pump companies (Asante Solutions and CeQur). He worked at Warburg Pincus LLC investing in diabetes technologies and was a long serving member of the Board of the Joslin Diabetes Center. He is a bioengineer from the University of Washington with an MBA from Stanford University.

Robert Gabbay MD, PhD

Robert Gabbay is an associate professor at Harvard Medical School and former Chief Scientific and Medical Officer of American Diabetes Association. Passionate diabetes executive with expertise in chronic care models, primary care transformation, technology, and digital health. Former CMO at Joslin, Harvard’s diabetes center. Recognized leader in diabetes research, innovation, and population health, featured in national and internation media like NY Times and CNN.